Results 201 to 210 of about 333,809 (260)

Dupilumab and cutaneous T-cell lymphoma: A retrospective cohort study. [PDF]

JAAD Int
Baghdasarian S, Al-Saedi O, Cuomo RE.
europepmc   +1 more source

Constructing an External Control Arm Using the French REALYSA Cohort to Replicate Outcomes of a Randomized Trial Arm in Advanced Hodgkin Lymphoma

Clinical Pharmacology &Therapeutics, EarlyView.
External control (EC) arms using routine data can be used as comparators in clinical trials under certain conditions. The objective of this study was to assess the ability of an EC arm to replicate outcomes of a randomized controlled trial (RCT) arm receiving the same treatment strategy in advanced stage classical Hodgkin lymphoma and serve as ...
Olivia Febvey‐Combes, Cédric Rossi, Behrouz Kassai, Tesla Murairi Mirimo, Loïc Chartier, Fanny Cherblanc, Emeline Cugnod, Hervé Ghesquières, Aurélien Belot   +8 more
wiley   +1 more source

A phase 1 trial of romidepsin, azacitidine, dexamethasone, and lenalidomide in relapsed or refractory T-cell lymphoma. [PDF]

Blood Adv
Gordon MJ, Miljkovic MD, Milhon P, Lakhotia R, Melani C, Johnson K, Bryant B, Pittaluga S, Jaffe ES, Conlon K, Staudt LM, Wilson WH, Roschewski M, Ng S.   +13 more
europepmc   +1 more source

From Prediction to Decision Making: PBPK and QSP as Regulatory‐Grade NAMs

Clinical Pharmacology &Therapeutics, EarlyView.
New approach methodologies (NAMs) encompass a diverse and rapidly evolving set of experimental and computational tools designed to generate human‐relevant mechanistic data for use in drug development and regulatory decision making. Experimental NAMs provide insights into drug disposition, pharmacological activity, and disease biology that are difficult
Karen Rowland Yeo, Piet H. van der Graaf
wiley   +1 more source

Treatment Patterns and Clinical Outcomes After Immunotherapy Failure in Patients With Natural Killer/T-Cell Lymphoma. [PDF]

Am J Hematol
Bai S, Song Y, Wang L, Liu F, Li Y, Qi S, Peng Z, Zhao Y, Huang H, Xia Y, Bai B, Fang X, Nie M, Cai J, Cao Y, Gao X, Zou Q, Cai Q, Zhang Y.   +18 more
europepmc   +1 more source

Initial preclinical investigation of aclarubicin treatment in primary cutaneous T-cell lymphoma cells. [PDF]

JID Innov
de Bie FJ, Dettingmeijer MD, de Haan S, Zoutman WH, van der Zanden SY, Tensen CP, Scheeren FA, Neefjes J, Vermeer MH.   +8 more
europepmc   +1 more source

Extranodal Natural Killer/T-Cell Lymphoma Presenting as Intestinal Stenosis and Perforation. [PDF]

Gastro Hep Adv
Li H, Yao L, Ouzhu M.
europepmc   +1 more source

HAVCR2 in subcutaneous panniculitis-like T cell lymphoma: comment on the article by Chambers et al. [PDF]

Arthritis Rheumatol
Chen AAY, Schwarzkopf R, Schrader KA, Chen LYC.   +3 more
europepmc   +1 more source

Systemic Epstein-Barr Virus-Positive T-Cell Lymphoma of Childhood: A Case Series. [PDF]

Pediatr Blood Cancer
Zarrabi M, Cahaney C, Schwartz LF, Kovach AE, Lin C, Stokke J.   +5 more
europepmc   +1 more source

Subcutaneous Panniculitis-Like T-cell Lymphoma With Scalp Involvement: A Diagnostic Challenge With Lupus Panniculitis. [PDF]

Cureus
Tamim Y, Berrada Y, El Hadadi F, Znati K, Meziane M, Ismaili N, Laila B, Senouci K.   +7 more
europepmc   +1 more source